Technical Analysis for COLL - Collegium Pharmaceutical, Inc.

Grade Last Price % Change Price Change
grade B 18.29 0.14% 0.03
COLL closed up 0.14 percent on Thursday, November 14, 2019, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical COLL trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.14%
Calm After Storm Range Contraction 0.14%
Upper Bollinger Band Walk Strength 0.14%
Wide Bands Range Expansion 0.14%
Overbought Stochastic Strength 0.14%

Older signals for COLL ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, focuses on developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an abuse-deterrent, extended-release, oral formulation of oxycodone, a prescribed opioid medication. The company is also developing COL-172, an abuse-deterrent, extended-release oxymorphone for the treatment of chronic pain; COL-195, an abuse-deterrent, extended-release hydrocodone for the treatment of chronic pain; COL-196, a morphine formulation for the treatment of pain; and COL-171, a proprietary preclinical DETERx extended-release, abuse-deterrent methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.
Pharmaceutical Diseases Pain Chemical Compounds Organic Compounds Euphoriants Chronic Pain Morphinans Platform Technology Attention Deficit Hyperactivity Disorder Ethers Opioids Phenols Hydrocodone Treatment Of Attention Deficit Hyperactivity Disorder Oxycodone Oxymorphone
Is COLL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.99
52 Week Low 10.01
Average Volume 439,280
200-Day Moving Average 13.2579
50-Day Moving Average 12.6995
20-Day Moving Average 14.2923
10-Day Moving Average 16.6325
Average True Range 1.0695
ADX 29.76
+DI 40.5242
-DI 15.6975
Chandelier Exit (Long, 3 ATRs ) 16.7815
Chandelier Exit (Short, 3 ATRs ) 14.3985
Upper Bollinger Band 20.3445
Lower Bollinger Band 8.2401
Percent B (%b) 0.83
BandWidth 84.691757
MACD Line 1.8548
MACD Signal Line 1.2782
MACD Histogram 0.5766
Fundamentals Value
Market Cap 540.77 Million
Num Shares 29.6 Million
EPS -3.59
Price-to-Earnings (P/E) Ratio -5.09
Price-to-Sales 40.60
Price-to-Book 3.16
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.67
Resistance 3 (R3) 19.63 19.12 19.44
Resistance 2 (R2) 19.12 18.77 19.15 19.36
Resistance 1 (R1) 18.71 18.55 18.92 18.75 19.29
Pivot Point 18.20 18.20 18.31 18.23 18.20
Support 1 (S1) 17.79 17.85 18.00 17.83 17.29
Support 2 (S2) 17.28 17.63 17.31 17.22
Support 3 (S3) 16.87 17.28 17.14
Support 4 (S4) 16.91